Search

Your search keyword '"Ilerigelen, B"' showing total 45 results
Start Over Author "Ilerigelen, B"
45 results on '"Ilerigelen, B"'

3. Coexisting dyslipidemia in hypertensive patients

Author

Ilerigelen, B, Buyukozturk, K, Kabakci, G, Koylan, N, and Kozan, O

Abstract

We point out that a peculiar annihilation of a vortex-antovortex pairobserved numerically by Hertel and Schneider [Phys. Rev. Lett. 97, 177202(2006)] represents the formation and subsequent decay of a skyrmion.

Published
2005

5. Electrocardiographic findings and prognosis in ischemic stroke

Author

Bozluolcay M, Ince B, Celik Y, Hande Harmanci, Ilerigelen B, and Pelin Z

Subjects
Adult, Aged, 80 and over, Male, Stroke, Electrocardiography, Predictive Value of Tests, Acute Disease, Humans, Female, Middle Aged, Prognosis, Aged, Brain Ischemia
Abstract

Electrocardiographic (ECG) changes are observed in patients with acute stroke and are related with the prognosis.To determine the frequency and significance of ECG changes in patients with acute ischemic stroke.In a prospective hospital-based study 87 patients with cerebral infarction were observed for ECG changes during their stay in the hospital. All the patients had ischemic stroke for the first time. The ECG changes observed were compared with those of the control group consisting of 87 patients.Of the 87 patients of the study group, 47.1% were females and 52.9% males. The mean age was 65.5 +/- 11.9 (range 31-91 yrs). The control group consisted of 50.6% females and 49.4% males. The mean age was 64.5 +/- 11.9 (range 31-87 yrs). The frequency of the ECG changes observed in patients with cerebral infarct was 62.1% while it was 29.9% in the control group (P0.0001). ECG changes observed were mostly related to myocardial ischemia. The six-month mortality rate in the patients with ECG changes was 38.9% whereas it was 15.2% in those with normal ECG (P0.05).The observations of this study suggest that cardiac evaluation in patients with acute ischemic stroke is of prognostic importance.

Published
2004

9. Effect of irbesartan monotherapy compared with ACE inhibitors and calcium channel blockers on patient compliance in patients with essential hypertension: A multicenter, randomized, open-cohort study

Author

Koylan, N, Acarturk, E, Caglar, N, Caglar, S, Erdine, S, Guneri, S, Ilerigelen, B, Ondokuz Mayıs Üniversitesi, and Çukurova Üniversitesi

Abstract

13th European Meeting on Hypertension -- JUN 13-17, 2003 -- MILAN, ITALY kabakci, giray/0000-0002-3275-7003 WOS: 000184406700254 … European Soc Hypertens

Published
2003

11. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study).

Author

Ilerigelen B, Uresin Y, San M, Kultursay H, Guneri S, Serdar OA, Gulec S, Pencedemir H, TULIPS Investigators, Ilerigelen, B, Uresin, Y, San, M, Kültürsay, H, Güneri, S, Serdar, O A, Güleç, S, and Pençedemir, H

Abstract

Objective: The efficacy and safety of extended-release fluvastatin (fluvastatin XL), 80 mg once daily, was assessed in Turkish patients with primary hypercholesterolaemia (low-density lipoprotein cholesterol (LDL-C) 3.37-5.70 mmol/l and triglyceride (TG) < 4.52 mmol/l).Research Design: In this open-label, prospective, multi-centre study, 154 patients were given fluvastatin XL 80 mg once daily and lipid levels were assessed after 2 and 12 weeks.Results: Fluvastatin XL 80 mg once daily significantly reduced LDL-C levels by 38.8 and 38.1% at weeks 2 (n = 140) and 12 (n = 116), respectively (p < 0.001 vs. baseline). Treatment with fluvastatin XL for 2 and 12 weeks significantly reduced total cholesterol levels by 30.2 and 27.4%, respectively (p < 0.001 vs. baseline) and reduced TG levels by 14.9 and 7.5%, respectively (p < 0.001 vs. baseline). Following stratification by risk factors for coronary heart disease (CHD) according to the National Cholesterol Education Program Adult Treatment Panel III guidelines, 87.3% of patients with > or = 2 risk factors, and 67.4% of patients with existing CHD or CHD risk equivalents achieved target LDL-C levels (< 3.37 mmol/l and < 2.59 mmol/l, respectively) with fluvastatin XL. Fluvastatin XL reduced high-density lipoprotein cholesterol by 8.9 and 4.7% at weeks 2 and 12 weeks, respectively. fluvastatin XL 80 mg once daily was generally well-tolerated.Conclusions: This open-label study indicates fluvastatin XL 80 mg once daily is an effective and well-tolerated lipid-lowering therapy for the reduction of CHD risk in Turkish patients. [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

29. Electrocardiographic findings and prognosis in ischemic stroke.

Author

Bozluolcay, M., Ince, B., Celik, V., Harmanci, H., Ilerigelen, B., and Pelin, Z.

Subjects
TRANSIENT ischemic attack, PROGNOSIS, CORONARY disease, CEREBRAL infarction, ELECTROCARDIOGRAPHY, MORTALITY
Abstract

Introduction: Electrocardiographic (ECG) changes are observed in patients with acute stroke and are related with the prognosis. Aims: To determine the frequency and significance of ECG changes in patients with acute ischemic stroke. Material and Methods: In a prospective hospital-based study 87 patients with cerebral infarction were observed for ECG changes during their stay in the hospital. All the patients had ischemic stroke for the first time. The ECG changes observed were compared with those of the control group consisting of 87 patients. Results: Of the 87 patients of the study group, 47.1% were females and 52.9% males. The mean age was 65.5 ± 11.9. (range 31-91 yrs). The control group consisted of 50.6% females and 49.4% males. The mean age was 64.5 ± 9.1 (range 31-87 yrs). The frequency of the ECG changes observed in patients with cerebral infarct was 62.1% while it was 29.9% in the control group (P<0.0001). ECG changes observed were mostly related to myocardial ischemia. The six-month mortality rate in the patients with ECG changes was 38.9% whereas it was 15.2% in those with normal ECG (P<0.05). Conclusions: The observations of this study suggest that cardiac evaluation in patients with acute ischemic stroke is of prognostic importance. [ABSTRACT FROM AUTHOR]

Published
2003

32. Türk hipertansiyon hastalarında mikroalbuminüri sıklığı ve ilişkili kardiyovasküler risk faktörleri

Author

V Çam, M Etemoglu, Sebahattin Ateşal, E Koçak, Bulent Polat, Meral Kayıkçıoğlu, Yekta Gürlertop, Cem Köz, Ö Özbek, H Yegin, Ceyhun Ceyhan, K Dönmez, B Tosun, H Atmaca, G Dönmez, B. ilerigelen, H Bozdemir, I Biyik, A Sökmen, F Koca, Kenan Övünç, Ramazan Topsakal, Sadi Gulec, O Tartanoglu, Kurtulus Ozdemir, A Fiskeci, E Akarca, Ahmet Sakalli, A Yavuz, M Bilaloglu, Giray Kabakci, T Keleş, F K Inceer, H Tunar, Ş Coşkun, M Şan, S C Turan, Serkan Topaloglu, Irem Dincer, S Yorganci, R Yoldaş, Ömer Kozan, I T Kurt, Mehmet İlker Gökçe, Hakan Kültürsay, A Yilmaz, C Genç, M Ö Sunay, K Tigen, A Sinci, T Ulusoy, Şükrü Ünal, Filiz Özerkan, Sinan Aydoğdu, H Bozkurt, N S Aran, Ercan Varol, O Sancaktar, A Delice, H Tikiz, Emin Evren Özcan, Fatih Sinan Ertaş, H Kaymak, E Semiz, C Rezzagil, I Susal, N Çam, F Özmen, Vedat Aytekin, S Çolak, A Keskin, E Acartürk, N Ata, Oben Döven, H Boga, H Vural, E Şensoy, A Lazoglu, I Özdogru, Y Balbay, Dursun Aras, J Jordan, Dilek Yeşilbursa, H Akgöz, E Onrat, Y Selçoki, Dilek Ural, R Uçar, Sinan Kahraman, H Gök, M T Sirkeci, T Peker, M Bilge, Mehmet Metin Seker, C Agçal, D Aytekin, S Toktaş, A Birdane, Y Yakar, A H Sözcüer, U Sümerkan, S Sakalli, Mehmet Oc, N Sönmez, M Bostan, A Akyüz, Adnan Abaci, V Koca, K Şahna, K Aytemir, Yuksel Cavusoglu, M Tahtasiz, Adalet Gürlek, O Ergene, V Gökçe, I Dogru, M Dagalp, Cuneyt Turkoglu, Ramazan Akdemir, C Uyan, Ahmet Vural, R Kargin, Enver Atalar, A Ünsal, A Bitigen, T T Gündogdu, Kaan Kulan, B Erol, A U Gülmez, Merih Kutlu, K Öztaş, I Tandogan, A Karanfil, Mustafa Polat, S Cinsoy, A Sert, M Çakmak, Ali Ergin, T Durmaz, A Aydinlar, P Pinar, A Kerpeten, Serdar Sevimli, Saide Aytekin, C Nazli, T Kirat, Zeynep Tartan, H Atasever, A Çamsari, A Aribaş, N Keser, Aydan Ongun Ozdemir, N Coşkun, Mehmet Yazici, Y Erzurum, Nevrez Koylan, Mustafa Yilmaz, M Ş Güçel, A E Kiliçoglu, O H Elönü, A Köşüş, G Topkara, G Daş, L Saraç, M Melek, D Gaffari, A Bayram, Z Tosun, K Kaya, Mahmut Şahin, Z Işilak, A Içli, Necla Ozer, Mustafa Kılıçkap, E Aygün, H Gündüz, H Öney, A Daver, Z Kaplan, M Gürsürer, Huseyin Arinc, A Irmak, Osman Alper Onbasili, F V Ulusoy, Mehmet Ridvan Yalcin, M Şerifi, Ahmet Temizhan, Ahmet Çelik, C Kirdar, S Mecit, Cihan Örem, A Güven, Kozan, Ö., Dokuz Eylül University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Özcan, E.E., Izmir Hospital, Izmir, Turkey -- Sancaktar, O., Istanbul Şafak Hospital, Istanbul, Turkey, Akdeniz University Medical Faculty, Department of Cardiology, Antalya, Turkey -- Kabakci, G., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Sözcüer, A.H., Merkez Efendi State Hospital, Cardiology Clinic, Manisa, Turkey -- Kerpeten, A., Kütahya State Hospital, Cardiology Clinic, Kütahya, Turkey -- Delice, A., Kizilay Health Center, Cardiology Polyclinic, Kayseri, Turkey -- Içli, A., Konya Municipality Hospital, Cardiology Clinic, Konya, Turkey -- Sökmen, A., Sütçü Imam University Medical Faculty, Department of Cardiology, Kahramanmaraş, Turkey -- Gürlek, A., Ankara University Medical Faculty, Department of Cardiology, Ibn-i Sina Hospital, Ankara, Turkey -- Abaci, A., Gazi University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Bayram, A., Erzurum Numune State Hospital, Cardiology Clinic, Erzurum, Turkey -- Köşüş, A., Ordu Medical Center, 19 Eylül Internal Diseases Polyclinic, Ordu, Turkey -- Çamsari, A., Mersin University Medical Faculty, Department of Cardiology, Mersin, Turkey -- Sakalli, A., Afyon State Hospital, Cardiology Clinic, Afyon, Turkey -- Sert, A., Beypazari State Hospital, Cardiology Clinic, Ankara, Turkey -- Temizhan, A., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Yilmaz, A., Cumhuriyet University Medical Faculty, Department of Cardiology, Sivas, Turkey -- Daver, A., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Aydinlar, A., Uludag University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Ergin, A., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Kiliçoglu, A.E., Elazig State Hospital, Cardiology Clinic, Elazig, Turkey -- Birdane, A., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Aribaş, A., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Lazoglu, A., Intermed Medical Center, Cardiology Clinic, Alanya, Antalya, Turkey -- Özdemir, A., 1 Eylül State Hospital, Cardiology Clinic, Uşak, Turkey -- Fiskeci, A., Balikesir State Hospital, Cardiology Clinic, Balikesir, Turkey -- Çelik, A., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Bitigen, A., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Keskin, A., Akhisar State Hospital, Cardiology Clinic, Manisa, Turkey -- Yavuz, A., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Akyüz, A., Sultan 1. Izzettin Keykavuş State Hospital, Cardiology Clinic, Sivas, Turkey -- Karanfil, A., Fatih University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Ünsal, A., Gölcük State Hospital, Cardiology Clinic, Kocaeli, Turkey -- Sinci, A., Bilecik State Hospital, Cardiology Clinic, Bilecik, Turkey -- Gülmez, A.U., Pamukkale State Hospital, Cardiology Clinic, Denizli, Turkey -- Irmak, A., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Vural, A., Toros State Hospital, Cardiology Clinic, Mersin, Turkey -- Güven, A., Sütçü Imam University Medical Faculty, Department of Cardiology, Kahramanmaraş, Turkey -- Ilerigelen, B., Istanbul University Cerrahpaşa Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Erol, B., Giresun State Hospital, Cardiology Clinic, Giresun, Turkey -- Polat, B., Polatli Duatepe State Hospital, Cardiology Clinic, Ankara, Turkey -- Tosun, B., Aydin 82. Yil State Hospital, Cardiology Clinic, Aydin, Turkey -- Agçal, C., Isparta State Hospital, Cardiology Clinic, Isparta, Turkey -- Genç, C., Gülhane Military Medical Academy, Department of Cardiology, Ankara, Turkey -- Kirdar, C., Eskişehir State Hospital, Cardiology Clinic, Eskişehir, Turkey -- Rezzagil, C., Şevket Yilmaz State Hospital, Cardiology Clinic, Bursa, Turkey -- Köz, C., Gülhane Military Medical Academy, Department of Cardiology, Ankara, Turkey -- Nazli, C., Atatürk Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Ceyhan, C., Adnan Menderes University Medical Faculty, Department of Cardiology, Aydin, Turkey -- Örem, C., Karadeniz Technical University Medical Faculty, Department of Cardiology, Trabzon, Turkey -- Uyan, C., Abant Izzet Baysal University Medical Faculty, Department of Cardiology, Bolu, Turkey -- Türkoglu, C., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Gaffari, D., Kizilay Health Center, Cardiology Polyclinic, Üsküdar, Istanbul, Turkey -- Aytekin, D., Salihli Public Hospital, Cardiology Clinic, Manisa, Turkey -- Ural, D., Kocaeli University Medical Faculty, Department of Cardiology, Kocaeli, Turkey -- Yeşilbursa, D., Uludag University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Aras, D., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Semiz, E., Pamukkale University Medical Faculty, Department of Cardiology, Denizli, Turkey -- Koçak, E., Evliya Çelebi State Hospital, Cardiology Clinic, Kütahya, Turkey -- Atalar, E., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Varol, E., Süleyman Demirel University Medical Faculty, Department of Cardiology, Isparta, Turkey -- Onrat, E., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Şensoy, E., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Acartürk, E., Çukurova University Medical Faculty, Department of Cardiology, Adana, Turkey -- Akarca, E., Nazilli State Hospital, Cardiology Clinic, Aydin, Turkey -- Aygün, E., Bafra State Hospital, Cardiology Clinic, Samsun, Turkey -- Ertaş, F.S., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Koca, F., Alsancak State Hospital, Cardiology Clinic, Izmir, Turkey -- Özmen, F., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Ulusoy, F.V., Ankara Numune Hospital, 2nd Cardiology Clinic, Ankara, Turkey -- Özerkan, F., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Inceer, F.K., Çorum State Hospital, Cardiology Clinic, Çorum, Turkey -- Dönmez, G., Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Topkara, G., Bandirma State Hospital, Cardiology Clinic, Balikesir, Turkey -- Daş, G., 82. Yil State Hospital, Cardiology Clinic, Adiyaman, Turkey -- Bozkurt, H., Antakya State Hospital, Cardiology Clinic, Antakya, Turkey -- Kültürsay, H., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Tikiz, H., Celal Bayar University Medical Faculty, Department of Cardiology, Manisa, Turkey -- Akgöz, H., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Kaymak, H., Tarsus State Hospital, Cardiology Clinic, Mersin, Turkey -- Öney, H., Artvin State Hospital, Cardiology Clinic, Artvin, Turkey -- Yegin, H., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Boga, H., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Gök, H., Selçuk State Hospital, Cardiology Clinic, Izmir, Turkey -- Vural, H., Vedat Ali Özkan State Hospital, Cardiology Clinic, Kayseri, Turkey -- Atasever, H., Adapazari State Hospital, Cardiology Clinic, Adapazari, Turkey -- Arinç, H., Izzet Baysal University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Bozdemir, H., Buca Seyfi Demirsoy State Hospital, Cardiology Clinic, Izmir, Turkey -- Gündüz, H., Izzet Baysal University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Tunar, H., Salihli State Hospital, Cardiology Clinic, Manisa, Turkey -- Atmaca, H., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Dogru, I., Çukurova State Hospital, Cardiology Clinic, Adana, Turkey -- Özdogru, I., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Susal, I., Karşiyaka State Hospital, Cardiology Clinic, Izmir, Turkey -- Kurt, I.T., Atakalp Heart Hospital, Cardiology Clinic, Izmir, Turkey -- Dinçer, I., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Biyik, I., Uşak State Hospital, Cardiology Clinic, Uşak, Turkey -- Tandogan, I., Cumhuriyet University Medical Faculty, Department of Cardiology, Sivas, Turkey -- Jordan, J., Uludag University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Kulan, K., Trabzon Numune State Hospital, Cardiology Clinic, Trabzon, Turkey -- Şahna, K., Ordu State Hospital, Cardiology Clinic, Ordu, Turkey -- Öztaş, K., Samsun State Hospital, Cardiology Clinic, Samsun, Turkey -- Dönmez, K., Manavgat State Hospital, Cardiology Clinic, Antalya, Turkey -- Övünç, K., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Kaya, K., Bursa State Hospital, Cardiology Clinic, Bursa, Turkey -- Aytemir, K., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Özdemir, K., Selçuk University Medical Faculty, Department of Cardiology, Konya, Turkey -- Tigen, K., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Saraç, L., Istinye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Sirkeci, M.T., Kizilay Health Center, Cardiology Polyclinic, Erzincan, Turkey -- Çakmak, M., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Şahin, M., Ondokuz Mayis University Medical Faculty, Department of Cardiology, Samsun, Turkey -- Kutlu, M., Harput State Hospital, Cardiology Clinic, Elazig, Turkey -- Bilge, M., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Bostan, M., Rize State Hospital, Cardiology Clinic, Rize, Turkey -- Melek, M., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Sunay, M.Ö., Balikesir State Hospital, Cardiology Clinic, Balikesir, Turkey -- Şeker, M., Meram State Hospital, Cardiology Clinic, Konya, Turkey -- Güçel, M.Ş., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Yazici, M., Düzce University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Kayikçioglu, M., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Öç, M., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Gürsürer, M., Karaelmas University Medical Faculty, Department of Cardiology, Zonguldak, Turkey -- Dagalp, M., Ziraat Bank Hospital, Cardiology Clinic, Ankara, Turkey -- Bilaloglu, M., Erzurum Numune State Hospital, Cardiology Clinic, Erzurum, Turkey -- Yalçin, M., GATA Haydarpaşa Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Şerifi, M., Izmit State Hospital, Cardiology Clinic, Kocaeli, Turkey -- Gökçe, M., Karadeniz Technical University Medical Faculty, Department of Cardiology, Trabzon, Turkey -- Kiliçkap, M., Ankara University Medical Faculty, Department of Cardiology, Heart Center, Ankara, Turkey -- Polat, M., Ceyhan State Hospital, Cardiology Clinic, Adana, Turkey -- Şan, M., Çukurova University Medical Faculty, Department of Cardiology, Adana, Turkey -- Tahtasiz, M., Eşrefpaşa Municipality Hospital, Cardiology Clinic, Izmir, Turkey -- Yilmaz, M., Kayseri State Hospital, Cardiology Clinic, Kayseri, Turkey -- Etemoglu, M., Izmir Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Coşkun, N., Harput State Hospital, Cardiology Clinic, Elazig, Turkey -- Aran, N.S., Istanbul University Cerrahpaşa Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Ata, N., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Sönmez, N., Bodrum State Hospital, Cardiology Clinic, Mugla, Turkey -- Çam, N., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Koylan, N., Istanbul University Istanbul Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Özer, N., Iskenderun State Hospital, Cardiology Clinic, Hatay, Turkey -- Keser, N., Maltepe University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Döven, O., Mersin University Medical Faculty, Department of Cardiology, Mersin, Turkey -- Tartanoglu, O., Karaman State Hospital, Cardiology Clinic, Karaman, Turkey -- Ergene, O., Atatürk Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Elönü, O.H., Melikgazi Hospital, Cardiology Clinic, Kayseri, Turkey -- Onbaşili, O.A., Adnan Menderes University Medical Faculty, Department of Cardiology, Aydin, Turkey -- Özbek, Ö., Marmara University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Pinar, P., Manisa State Hospital, Cardiology Clinic, Manisa, Turkey -- Akdemir, R., Düzce University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Kargin, R., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Topsakal, R., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Yoldaş, R., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Uçar, R., Giresun State Hospital, Cardiology Clinic, Giresun, Turkey -- Ateşal, S., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Toktaş, S., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Cinsoy, S., Sabuncuoglu Şerafeddin State Hospital, Cardiology Clinic, Amasya, Turkey -- Güleç, S., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Aytekin, S., Kadir Has University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Çolak, S., Kizilay Health Center, Cardiology Polyclinic, Sivas, Turkey -- Mecit, S., Çanakkale Şehitlik State Hospital, Cardiology Clinic, Çanakkale, Turkey -- Sakalli, S., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Sevimli, S., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Topaloglu, S., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Aydogdu, S., Ankara Numune Hospital, Cardiology Clinic, Ankara, Turkey -- Turan, S.C., Fatih Sultan Mehmet State Hospital, Cardiology Clinic, Istanbul, Turkey -- Kahraman, S., Nigde State Hospital, Cardiology Clinic, Nigde, Turkey -- Yorganci, S., Atatürk State Hospital, Cardiology Clinic, Antalya, Turkey -- Coşkun, Ş., Bursa State Hospital, Cardiology Clinic, Bursa, Turkey -- Ünal, Ş., Nevşehir State Hospital, Cardiology Clinic, Nevşehir, Turkey -- Durmaz, T., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Ulusoy, T., Aksaray State Hospital, Cardiology Clinic, Aksaray, Turkey -- Keleş, T., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Kirat, T., Mugla State Hospital, Cardiology Clinic, Mugla, Turkey -- Gündogdu, T.T., Gebze Fatih Hospital, Cardiology Clinic, Kocaeli, Turkey -- Peker, T., Gemlik State Hospital, Cardiology Clinic, Bursa, Turkey -- Sümerkan, U., Marmara University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Aytekin, V., Kadir Has University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Koca, V., Bursa Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Bursa, Turkey -- Çam, V., Fethiye State Hospital, Cardiology Clinic, Mugla, Turkey -- Gökçe, V., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Gürlertop, Y., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Balbay, Y., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Çavuşoglu, Y., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Erzurum, Y., Eskişehir Yunus Emre State Hospital, Cardiology Clinic, Eskişehir, Turkey -- Selçoki, Y., Fatih University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Yakar, Y., Tokat State Hospital, Cardiology Clinic, Tokat, Turkey -- Işilak, Z., GATA Haydarpaşa Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Tosun, Z., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Kaplan, Z., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Tartan, Z., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey, Zonguldak Bülent Ecevit Üniversitesi, 0-Belirlenecek, Ondokuz Mayıs Üniversitesi, BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Uyan, Cihangir, Aytekin, Saide, Aytekin, Vedat, Kozan, Ö., Dokuz Eylül University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Özcan, E.E., Izmir Hospital, Izmir, Turkey -- Sancaktar, O., Istanbul Şafak Hospital, Istanbul, Turkey, Akdeniz University Medical Faculty, Department of Cardiology, Antalya, Turkey -- Kabakci, G., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Sözcüer, A.H., Merkez Efendi State Hospital, Cardiology Clinic, Manisa, Turkey -- Kerpeten, A., Kütahya State Hospital, Cardiology Clinic, Kütahya, Turkey -- Delice, A., Kizilay Health Center, Cardiology Polyclinic, Kayseri, Turkey -- Içli, A., Konya Municipality Hospital, Cardiology Clinic, Konya, Turkey -- Sökmen, A., Sütçü Imam University Medical Faculty, Department of Cardiology, Kahramanmaraş, Turkey -- Gürlek, A., Ankara University Medical Faculty, Department of Cardiology, Ibn-i Sina Hospital, Ankara, Turkey -- Abaci, A., Gazi University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Bayram, A., Erzurum Numune State Hospital, Cardiology Clinic, Erzurum, Turkey -- Köşüş, A., Ordu Medical Center, 19 Eylül Internal Diseases Polyclinic, Ordu, Turkey -- Çamsari, A., Mersin University Medical Faculty, Department of Cardiology, Mersin, Turkey -- Sakalli, A., Afyon State Hospital, Cardiology Clinic, Afyon, Turkey -- Sert, A., Beypazari State Hospital, Cardiology Clinic, Ankara, Turkey -- Temizhan, A., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Yilmaz, A., Cumhuriyet University Medical Faculty, Department of Cardiology, Sivas, Turkey -- Daver, A., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Aydinlar, A., Uluda? University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Ergin, A., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Kiliço?lu, A.E., Elazi? State Hospital, Cardiology Clinic, Elazi?, Turkey -- Birdane, A., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Aribaş, A., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Lazo?lu, A., Intermed Medical Center, Cardiology Clinic, Alanya, Antalya, Turkey -- Özdemir, A., 1 Eylül State Hospital, Cardiology Clinic, Uşak, Turkey -- Fiskeci, A., Balikesir State Hospital, Cardiology Clinic, Balikesir, Turkey -- Çelik, A., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Bitigen, A., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Keskin, A., Akhisar State Hospital, Cardiology Clinic, Manisa, Turkey -- Yavuz, A., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Akyüz, A., Sultan 1. Izzettin Keykavuş State Hospital, Cardiology Clinic, Sivas, Turkey -- Karanfil, A., Fatih University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Ünsal, A., Gölcük State Hospital, Cardiology Clinic, Kocaeli, Turkey -- Sinci, A., Bilecik State Hospital, Cardiology Clinic, Bilecik, Turkey -- Gülmez, A.U., Pamukkale State Hospital, Cardiology Clinic, Denizli, Turkey -- Irmak, A., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Vural, A., Toros State Hospital, Cardiology Clinic, Mersin, Turkey -- Güven, A., Sütçü Imam University Medical Faculty, Department of Cardiology, Kahramanmaraş, Turkey -- Ilerigelen, B., Istanbul University Cerrahpaşa Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Erol, B., Giresun State Hospital, Cardiology Clinic, Giresun, Turkey -- Polat, B., Polatli Duatepe State Hospital, Cardiology Clinic, Ankara, Turkey -- Tosun, B., Aydin 82. Yil State Hospital, Cardiology Clinic, Aydin, Turkey -- A?çal, C., Isparta State Hospital, Cardiology Clinic, Isparta, Turkey -- Genç, C., Gülhane Military Medical Academy, Department of Cardiology, Ankara, Turkey -- Kirdar, C., Eskişehir State Hospital, Cardiology Clinic, Eskişehir, Turkey -- Rezzagil, C., Şevket Yilmaz State Hospital, Cardiology Clinic, Bursa, Turkey -- Köz, C., Gülhane Military Medical Academy, Department of Cardiology, Ankara, Turkey -- Nazli, C., Atatürk Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Ceyhan, C., Adnan Menderes University Medical Faculty, Department of Cardiology, Aydin, Turkey -- Örem, C., Karadeniz Technical University Medical Faculty, Department of Cardiology, Trabzon, Turkey -- Uyan, C., Abant Izzet Baysal University Medical Faculty, Department of Cardiology, Bolu, Turkey -- Türko?lu, C., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Gaffari, D., Kizilay Health Center, Cardiology Polyclinic, Üsküdar, Istanbul, Turkey -- Aytekin, D., Salihli Public Hospital, Cardiology Clinic, Manisa, Turkey -- Ural, D., Kocaeli University Medical Faculty, Department of Cardiology, Kocaeli, Turkey -- Yeşilbursa, D., Uluda? University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Aras, D., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Semiz, E., Pamukkale University Medical Faculty, Department of Cardiology, Denizli, Turkey -- Koçak, E., Evliya Çelebi State Hospital, Cardiology Clinic, Kütahya, Turkey -- Atalar, E., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Varol, E., Süleyman Demirel University Medical Faculty, Department of Cardiology, Isparta, Turkey -- Onrat, E., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Şensoy, E., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Acartürk, E., Çukurova University Medical Faculty, Department of Cardiology, Adana, Turkey -- Akarca, E., Nazilli State Hospital, Cardiology Clinic, Aydin, Turkey -- Aygün, E., Bafra State Hospital, Cardiology Clinic, Samsun, Turkey -- Ertaş, F.S., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Koca, F., Alsancak State Hospital, Cardiology Clinic, Izmir, Turkey -- Özmen, F., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Ulusoy, F.V., Ankara Numune Hospital, 2nd Cardiology Clinic, Ankara, Turkey -- Özerkan, F., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Inceer, F.K., Çorum State Hospital, Cardiology Clinic, Çorum, Turkey -- Dönmez, G., Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Topkara, G., Bandirma State Hospital, Cardiology Clinic, Balikesir, Turkey -- Daş, G., 82. Yil State Hospital, Cardiology Clinic, Adiyaman, Turkey -- Bozkurt, H., Antakya State Hospital, Cardiology Clinic, Antakya, Turkey -- Kültürsay, H., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Tikiz, H., Celal Bayar University Medical Faculty, Department of Cardiology, Manisa, Turkey -- Akgöz, H., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Kaymak, H., Tarsus State Hospital, Cardiology Clinic, Mersin, Turkey -- Öney, H., Artvin State Hospital, Cardiology Clinic, Artvin, Turkey -- Ye?in, H., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Bo?a, H., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Gök, H., Selçuk State Hospital, Cardiology Clinic, Izmir, Turkey -- Vural, H., Vedat Ali Özkan State Hospital, Cardiology Clinic, Kayseri, Turkey -- Atasever, H., Adapazari State Hospital, Cardiology Clinic, Adapazari, Turkey -- Arinç, H., Izzet Baysal University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Bozdemir, H., Buca Seyfi Demirsoy State Hospital, Cardiology Clinic, Izmir, Turkey -- Gündüz, H., Izzet Baysal University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Tunar, H., Salihli State Hospital, Cardiology Clinic, Manisa, Turkey -- Atmaca, H., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Do?ru, I., Çukurova State Hospital, Cardiology Clinic, Adana, Turkey -- Özdo?ru, I., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Susal, I., Karşiyaka State Hospital, Cardiology Clinic, Izmir, Turkey -- Kurt, I.T., Atakalp Heart Hospital, Cardiology Clinic, Izmir, Turkey -- Dinçer, I., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Biyik, I., Uşak State Hospital, Cardiology Clinic, Uşak, Turkey -- Tando?an, I., Cumhuriyet University Medical Faculty, Department of Cardiology, Sivas, Turkey -- Jordan, J., Uluda? University Medical Faculty, Department of Cardiology, Bursa, Turkey -- Kulan, K., Trabzon Numune State Hospital, Cardiology Clinic, Trabzon, Turkey -- Şahna, K., Ordu State Hospital, Cardiology Clinic, Ordu, Turkey -- Öztaş, K., Samsun State Hospital, Cardiology Clinic, Samsun, Turkey -- Dönmez, K., Manavgat State Hospital, Cardiology Clinic, Antalya, Turkey -- Övünç, K., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Kaya, K., Bursa State Hospital, Cardiology Clinic, Bursa, Turkey -- Aytemir, K., Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Özdemir, K., Selçuk University Medical Faculty, Department of Cardiology, Konya, Turkey -- Tigen, K., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Saraç, L., Istinye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Sirkeci, M.T., Kizilay Health Center, Cardiology Polyclinic, Erzincan, Turkey -- Çakmak, M., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Şahin, M., Ondokuz Mayis University Medical Faculty, Department of Cardiology, Samsun, Turkey -- Kutlu, M., Harput State Hospital, Cardiology Clinic, Elazi?, Turkey -- Bilge, M., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Bostan, M., Rize State Hospital, Cardiology Clinic, Rize, Turkey -- Melek, M., Afyon Kocatepe University Medical Faculty, Department of Cardiology, Afyon, Turkey -- Sunay, M.Ö., Balikesir State Hospital, Cardiology Clinic, Balikesir, Turkey -- Şeker, M., Meram State Hospital, Cardiology Clinic, Konya, Turkey -- Güçel, M.Ş., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Yazici, M., Düzce University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Kayikçio?lu, M., Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey -- Öç, M., Ümraniye State Hospital, Cardiology Clinic, Istanbul, Turkey -- Gürsürer, M., Karaelmas University Medical Faculty, Department of Cardiology, Zonguldak, Turkey -- Da?alp, M., Ziraat Bank Hospital, Cardiology Clinic, Ankara, Turkey -- Bilalo?lu, M., Erzurum Numune State Hospital, Cardiology Clinic, Erzurum, Turkey -- Yalçin, M., GATA Haydarpaşa Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Şerifi, M., Izmit State Hospital, Cardiology Clinic, Kocaeli, Turkey -- Gökçe, M., Karadeniz Technical University Medical Faculty, Department of Cardiology, Trabzon, Turkey -- Kiliçkap, M., Ankara University Medical Faculty, Department of Cardiology, Heart Center, Ankara, Turkey -- Polat, M., Ceyhan State Hospital, Cardiology Clinic, Adana, Turkey -- Şan, M., Çukurova University Medical Faculty, Department of Cardiology, Adana, Turkey -- Tahtasiz, M., Eşrefpaşa Municipality Hospital, Cardiology Clinic, Izmir, Turkey -- Yilmaz, M., Kayseri State Hospital, Cardiology Clinic, Kayseri, Turkey -- Etemo?lu, M., Izmir Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Coşkun, N., Harput State Hospital, Cardiology Clinic, Elazi?, Turkey -- Aran, N.S., Istanbul University Cerrahpaşa Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Ata, N., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Sönmez, N., Bodrum State Hospital, Cardiology Clinic, Mu?la, Turkey -- Çam, N., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Koylan, N., Istanbul University Istanbul Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Özer, N., Iskenderun State Hospital, Cardiology Clinic, Hatay, Turkey -- Keser, N., Maltepe University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Döven, O., Mersin University Medical Faculty, Department of Cardiology, Mersin, Turkey -- Tartano?lu, O., Karaman State Hospital, Cardiology Clinic, Karaman, Turkey -- Ergene, O., Atatürk Training and Research Hospital, Cardiology Clinic, Izmir, Turkey -- Elönü, O.H., Melikgazi Hospital, Cardiology Clinic, Kayseri, Turkey -- Onbaşili, O.A., Adnan Menderes University Medical Faculty, Department of Cardiology, Aydin, Turkey -- Özbek, Ö., Marmara University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Pinar, P., Manisa State Hospital, Cardiology Clinic, Manisa, Turkey -- Akdemir, R., Düzce University Medical Faculty, Department of Cardiology, Düzce, Turkey -- Kargin, R., Kartal Koşuyolu Training and Research Hospital, Cardiology Clinic, Istanbul, Turkey -- Topsakal, R., Erciyes University Medical Faculty, Department of Cardiology, Kayseri, Turkey -- Yoldaş, R., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Uçar, R., Giresun State Hospital, Cardiology Clinic, Giresun, Turkey -- Ateşal, S., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Toktaş, S., Adana Numune Training and Research Hospital, Fatma Timurçin Heart Center, Adana, Turkey -- Cinsoy, S., Sabuncuo?lu Şerafeddin State Hospital, Cardiology Clinic, Amasya, Turkey -- Güleç, S., Ankara University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Aytekin, S., Kadir Has University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Çolak, S., Kizilay Health Center, Cardiology Polyclinic, Sivas, Turkey -- Mecit, S., Çanakkale Şehitlik State Hospital, Cardiology Clinic, Çanakkale, Turkey -- Sakalli, S., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey -- Sevimli, S., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Topalo?lu, S., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Aydo?du, S., Ankara Numune Hospital, Cardiology Clinic, Ankara, Turkey -- Turan, S.C., Fatih Sultan Mehmet State Hospital, Cardiology Clinic, Istanbul, Turkey -- Kahraman, S., Ni?de State Hospital, Cardiology Clinic, Ni?de, Turkey -- Yorganci, S., Atatürk State Hospital, Cardiology Clinic, Antalya, Turkey -- Coşkun, Ş., Bursa State Hospital, Cardiology Clinic, Bursa, Turkey -- Ünal, Ş., Nevşehir State Hospital, Cardiology Clinic, Nevşehir, Turkey -- Durmaz, T., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Ulusoy, T., Aksaray State Hospital, Cardiology Clinic, Aksaray, Turkey -- Keleş, T., Ankara Atatürk Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Kirat, T., Mu?la State Hospital, Cardiology Clinic, Mu?la, Turkey -- Gündo?du, T.T., Gebze Fatih Hospital, Cardiology Clinic, Kocaeli, Turkey -- Peker, T., Gemlik State Hospital, Cardiology Clinic, Bursa, Turkey -- Sümerkan, U., Marmara University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Aytekin, V., Kadir Has University Medical Faculty, Department of Cardiology, Istanbul, Turkey -- Koca, V., Bursa Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Bursa, Turkey -- Çam, V., Fethiye State Hospital, Cardiology Clinic, Mu?la, Turkey -- Gökçe, V., Konya Numune State Hospital, Cardiology Clinic, Konya, Turkey -- Gürlertop, Y., Atatürk University Medical Faculty, Department of Cardiology, Erzurum, Turkey -- Balbay, Y., Ankara Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Çavuşo?lu, Y., Osmangazi University Medical Faculty, Department of Cardiology, Eskişehir, Turkey -- Erzurum, Y., Eskişehir Yunus Emre State Hospital, Cardiology Clinic, Eskişehir, Turkey -- Selçoki, Y., Fatih University Medical Faculty, Department of Cardiology, Ankara, Turkey -- Yakar, Y., Tokat State Hospital, Cardiology Clinic, Tokat, Turkey -- Işilak, Z., GATA Haydarpaşa Training and Research Hospital, Department of Cardiology, Istanbul, Turkey -- Tosun, Z., Antalya State Hospital, Cardiology Clinic, Antalya, Turkey -- Kaplan, Z., Ankara Training and Research Hospital, Cardiology Clinic, Ankara, Turkey -- Tartan, Z., Siyami Ersek Hospital, Cardiology Clinic, Istanbul, Turkey, Maltepe Üniversitesi, and Çukurova Üniversitesi

Subjects
Male, heart atrium fibrillation, Turkey, Cross-sectional study, urinalysis, anticoagulant agent, Coronary artery disease, Turkey (republic), hydroxymethylglutaryl coenzyme A reductase inhibitor, low density lipoprotein cholesterol, sedentary lifestyle, Risk Factors, high density lipoprotein cholesterol, cardiovascular disease, middle aged, dipeptidyl carboxypeptidase inhibitor, Albuminuria/complications/epidemiology, Cardiovascular diseases, Hypertension/complications, Prevalence, Risk factors, Turkey/epidemiology, Medicine, Family history, family history, education.field_of_study, C reactive protein, adult, creatinine, article, beta adrenergic receptor blocking agent, clinical trial, antithrombocytic agent, Middle Aged, urine, comorbidity, ComputingMilieux_MANAGEMENTOFCOMPUTINGANDINFORMATIONSYSTEMS, female, congestive heart failure, risk factor, laboratory test, diabetes mellitus, Hypertension, antihypertensive agent, Female, triacylglycerol, InformationSystems_MISCELLANEOUS, Cardiology and Cardiovascular Medicine, cardiovascular risk, Adult, disease control, medicine.medical_specialty, microalbuminuria, heart infarction, Population, Urinalysis, albuminuria, smoking, Young Adult, blood, Internal medicine, cross-sectional study, Albuminuria, Humans, human, Risk factor, Intensive care medicine, education, Triglycerides, concentration (parameters), business.industry, screening, dyslipidemia, Cholesterol, HDL, ComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKS, cholesterol, Cholesterol, LDL, medicine.disease, major clinical study, Comorbidity, brain ischemia, predictor variable, multicenter study, Cross-Sectional Studies, ComputingMethodologies_PATTERNRECOGNITION, transient ischemic attack, observational study, Microalbuminuria, disease duration, business, Dyslipidemia, peripheral occlusive artery disease
Abstract

PubMed ID: 22257801, Objectives: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Study design: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. Results: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Conclusion: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients. © 2011 Turkish Society of Cardiology.

Published
2011

33. Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome.

Author

Sipahioglu NT, Ilerigelen B, Gungor ZB, Ayaz G, Ekmekci H, Gurel CB, Can G, Sonmez H, Ulutin T, and Sipahioglu F

Subjects
Adult, Blood Glucose metabolism, Body Mass Index, C-Reactive Protein metabolism, Female, Humans, Lipoproteins, LDL blood, Male, Metabolic Syndrome blood, Middle Aged, Nitric Oxide Synthase Type III blood, Oxidative Stress physiology, Smoking, Metabolic Syndrome metabolism, Metabolic Syndrome pathology, Vasodilation physiology
Abstract

Background: Metabolic syndrome (MetS) is one of the high cardiovascular (CV) situations. Endothelial dysfunction, which is a common finding in patients with MetS, is related with increased CV risk. In patients with MetS, the effect of the major CV risk factors, not included in the MetS definition, on endothelial dysfunction is not well known. The aim of this study was to determine the effect of major CV risk factors such as gender, smoking, family history, and biochemical parameters on endothelial dysfunction in patients with MetS., Methods: The study was performed between December 2010 and August 2014. A total of 55 patients (15 females and 40 males) with MetS and 81 healthy controls (37 females and 44 males) with a body mass index <25 kg/m2 were enrolled in the study. Endothelial dysfunction was measured by flow-mediated dilatation (FMD), oxidative stress parameters; high-sensitivity C-reactive protein (hs-CRP), oxidized low-density lipoprotein (ox-LDL), endothelial nitric oxide synthase (e-NOS), nitric oxide, and cell adhesion markers; von Willebrand factor, and e-selectin. Platelet aggregation (endothelial adenosine diphosphate), total platelet count, and mean platelet volume were additionally analyzed and demographic parameters were explored. Student's t- test, Mann-Whitney U-test, and Chi-square test were used to analyze the results., Results: The fasting blood glucose (z= 3.52, P= 0.001), hs-CRP (z = 3.23, P= 0.004), ox-LDL (z = 2.62, P= 0.013), and e-NOS (z = 2.22, P= 0.026) levels and cardiac risk score (z = 5.23, P< 0.001) were significantly higher in patients with MetS compared with the control group. Smoking was correlated with decreased FMD (χ2 = 9.26, P= 0.002) in MetS patients but not in the control group., Conclusions: Increased ox-LDL, hs-CRP, and e-NOS are likely to be a result of oxidative stress, a condition in which an imbalance occurs between the production and inactivation of reactive nitrogen and oxygen species. In addition, in patients with MetS, smoking is independently related to endothelial dysfunction.

Published
2017
Full Text
View/download PDF

34. Endothelial Dysfunction Markers in Low Cardiovascular Risk Individuals: Comparison of Males and Females.

Author

Gungor ZB, Sipahioglu N, Sonmez H, Ekmekci H, Toprak S, Ayaz G, Gurel CB, Mutlu T, Ulutin T, Sipahioglu F, and Ilerigelen B

Abstract

Background: Cardiovascular diseases (CVD) account for approximately 50% of the total deaths in Turkey. Most of them are related with atherosclerotic coronary heart disease. Predictive value of endothelial dysfunction markers related with the earliest stage of atherosclerosis has been getting more attention. We hypothesized that differences in endothelial dysfunction biochemical markers among genders would aid to capture proatherogenic activity that was not diagnosed by conventional risk assessment scoring systems., Methods: We assessed the endothelial dysfuntion markers in 92 Turkish adults who were in the »low CV risk group« according to ESC (European Society of Cardiology)-Score Risk Charts. We compared the males and females., Results: We observed higher endothelial dysfunction rates in males, with higher median and mean levels of e-NOS, ox-LDL before and after adjustment for HDL lowness and obesity (P=0.018, P=0.036 for NOS; P=0.000, P=0.004 for ox-LDL, respectively). Men had higher hs-CRP levels than females before adjustment (P=0.021). Decreased e-NOS levels were related with FMD for females before adjustment for confounders (P=0.028). We also found significant correlation between e-NOS and ox-LDL levels both before (r=0.360, P<0.001) and after adjustment (r=0.366, P<0.01) for confounders which pointed out the nitrosative stress. In multivariate regression analyses, after adjusting for other endothelial dysfunction markers which were not included in the ESC-risk scoring system, decreased e-NOS levels were independently asssociated with impaired flow mediated dilatation for females (odds ratio 0.3; P=0.038)., Conclusions: Our results underline the importance of gender in evaluating endothelial dysfunction biochemical markers to assess cardiovascular risk for low CV risk indivuals., Competing Interests: Conflict of interest statement The authors stated that they have no conflicts of interest regarding the publication of this article.

Published
2017
Full Text
View/download PDF

35. Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW).

Author

Kızılırmak P, Ar I, and Ilerigelen B

Subjects
Administration, Oral, Aged, Blood Pressure, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Hypertension physiopathology, Male, Middle Aged, Treatment Outcome, Turkey, Valine administration & dosage, Valsartan, Amlodipine administration & dosage, Antihypertensive Agents administration & dosage, Hypertension drug therapy, Tetrazoles administration & dosage, Valine analogs & derivatives
Abstract

Objectives: This study evaluated the efficacy as well as the safety and tolerability profile of low-dose valsartan/amlodipine (Val/Amlo) single-pill combination (SPC) (160/5 mg) in patients with essential hypertension in Turkey., Study Design: Adult patients with essential hypertension [systolic blood pressure (SBP)>140 mmHg and/or diastolic blood pressure (DBP)>90 mmHg], who were on low dose Val/Amlo (160/5 mg) SPC before enrollment and gave informed consent, were accepted for this multi-centric observational study performed at 30 sites. The absolute changes in SBP and DBP from baseline were the primary efficacy outcomes. Safety assessments consisted of recording all adverse events., Results: Of 381 patients enrolled, 327 completed the study; 39% were females. The mean age was 57.3±11.8 years. Median duration of hypertension was 38 months. Both SBP and DBP values showed reductions from 162.6±16.6 mmHg and 94.0±13.2 mmHg to 137.6±14.2 mmHg and 81.9±9.0 mmHg at 4th week and to 131.6±11.5 mmHg and 79.7±7.6 mmHg at 12th week, respectively. The control and response rates at the end of the study were 82.0% and 92.6%, respectively. Twelve patients (3.2%) experienced a total of 12 adverse events; there were no serious adverse events. The most common adverse event was edema (1.3%). Patient compliance was approximately 99%., Conclusion: Low-dose (160/5 mg) Val/Amlo SPC is efficacous and has a good tolerability and safety profile for the management of essential hypertension in Turkey.

Published
2014
Full Text
View/download PDF

36. The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.

Author

Ayaz G, Batar B, Kanigur G, Guven M, Onaran I, Karadag B, Ilerigelen B, Dirican A, and Ulutin T

Subjects
ATP Binding Cassette Transporter, Subfamily B, Adult, Aged, Aged, 80 and over, Case-Control Studies, Coronary Artery Disease blood, Female, Gene Frequency, Genetic Association Studies, Haplotypes, Humans, Male, Middle Aged, Multivariate Analysis, Risk, Turkey, ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics, Coronary Artery Disease genetics, Platelet Activating Factor metabolism, Polymorphism, Single Nucleotide
Abstract

Increased levels of peripheral proinflammatory mediators can contribute to the development of coronary artery disease (CAD). Platelet activating factor (PAF) is an important proinflammatory mediator and plasma levels of PAF correlate with transmembrane transporter multidrug resistant 1 P-glycoprotein (MDR1 Pgp) expression and activity. MDR1 polymorphisms can affect the expression and activity of Pgp and plasma PAF levels. Therefore, we investigated the possible relationship between MDR1 C3435T and G2677T/A polymorphisms and plasma PAF levels and the risk of CAD. The study population consisted of 198 patients angiographically documented CAD, including 113 cases with at least 1 coronary artery with ≥50% luminal diameter stenosis and 85 control subjects with strictly normal coronary angiograms. Genotypes of the MDR1 C3435T and G2677T/A polymorphisms were determined by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP). Plasma PAF levels were detected by enzyme-linked immunosorbent assay (ELISA). There were no significant differences among plasma PAF levels in regard to MDR1 C3435T and G2677T polymorphisms in CAD patients and controls. No statistically significant difference was found for the genotypic and allelic distributions of the polymorphisms in the MDR1 gene between the patients and the control subjects. Furthermore, analysis of MDR1 haplotypes did not show any associations with increased plasma PAF levels and risk of CAD. Our results suggest that plasma PAF levels are not associated with MDR1 gene polymorphisms. There is no association between MDR1 C3435T and G2677T/A polymorphisms and the risk of CAD in Turkish patients., (© 2013.)

Published
2013
Full Text
View/download PDF

37. Effect on quality of life of different accelerated diagnostic protocols for management of patients presenting to the emergency department with acute chest pain.

Author

Nucifora G, Badano LP, Sarraf-Zadegan N, Karavidas A, Trocino G, Scaffidi G, Pettinati G, Astarita C, Vysniauskas V, Gregori D, Ilerigelen B, and Fioretti PM

Subjects
Activities of Daily Living, Acute Disease, Echocardiography, Stress, Electrocardiography, Humans, Myocardial Ischemia complications, Myocardial Ischemia drug therapy, Risk Assessment, Surveys and Questionnaires, Chest Pain etiology, Emergency Service, Hospital, Myocardial Ischemia diagnosis, Quality of Life
Abstract

This study assessed the effects on quality of life (QoL) of dobutamine-atropine stress echocardiography (DASE) and electrocardiogram exercise testing (EET) accelerated diagnostic protocols for early stratification of low-risk patients with acute chest pain (ACP). A total of 290 patients with ACP, a nondiagnostic electrocardiogram, and negative biomarkers were randomly assigned to an accelerated diagnostic protocol (DASE, n = 110, or EET, n = 89) or usual care (n = 91) and followed up for 2 months. QoL was assessed at discharge and 2-month follow-up using the Nottingham Health Profile questionnaire. Baseline and 2-month follow-up answers to the Nottingham Health Profile questionnaire were available for 207 patients (71%; 55 in the usual-care, 77 in the DASE, and 75 in the ETT arm). At predischarge, patients in the usual-care arm reported higher impairment in the physical mobility and pain dimensions compared with the DASE and EET arms (p = 0.019 and p = 0.023, respectively). At 2-month follow-up, QoL improved in all groups; however, patients in the usual-care arm had significantly worse scores than patients managed using accelerated diagnostic protocols in the physical mobility, pain, social isolation, emotional reactions, and energy level dimensions (p = 0.014, p = 0.002, p = 0.04, p = 0.01, and p = 0.003, respectively). In conclusion, low-risk patients with ACP had non-negligible impairment of QoL in the acute phase. Emergency department ADPs with early DASE and EET reduced QoL impairment at both baseline and 2-month follow-up.

Published
2009
Full Text
View/download PDF

38. Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study.

Author

Kabakci G, Koylan N, Ilerigelen B, Kozan O, and Buyukozturk K

Abstract

Background: Hypertension, dyslipidemia, and other cardiovascular risk factors are linked epidemiologically, clinically, and metabolically. Intensive/Initial Cardiovascular Examination regarding Blood Pressure levels, Evaluation of Risk Groups (ICEBERG) study focuses on the effect of dyslipidemia on cardiovascular risk evaluation and association of lipid profile with other risk factors., Patients and Methods: The ICEBERG study consisted of two sub-protocols: ICEBERG-1, conducted at 20 university hospitals (Referral Group) and ICEBERG-2, conducted at 197 primary healthcare centers (Primary Care Group). Sub-protocol had two patient profiles: patients previously diagnosed with essential hypertension and under medical treatment (Treated Group) and patients with systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, with no antihypertensive treatment for at least 3 months before inclusion (Untreated Group). Dyslipidemia was evaluated and cardiovascular risk stratification was performed according to ESC/ESH guidelines., Results: More than half of the treated and untreated subjects were classified into high or very high cardiovascular risk groups. In a total of 1817 patients, the percentage of patients in "high" plus "very high" added risk groups increased to 55.2% in Treated Referral Group (p < 0.001), to 62.6% in Untreated Referral Group (p = 0.25) and to 60.7% in Untreated Primary Care Group (p < 0.001), by re-evaluation of patients' lipid values., Conclusions: Serum lipid levels are useful in stratifying hypertensive patients into cardiovascular risk groups more accurately, for appropriate antihypertensive treatment.

Published
2008
Full Text
View/download PDF

39. Comparison of early dobutamine stress echocardiography and exercise electrocardiographic testing for management of patients presenting to the emergency department with chest pain.

Author

Nucifora G, Badano LP, Sarraf-Zadegan N, Karavidas A, Trocino G, Scaffidi G, Pettinati G, Astarita C, Vysniauskas V, Gregori D, Ilerigelen B, Marinigh R, and Fioretti PM

Subjects
Female, Humans, Length of Stay economics, Male, Middle Aged, Prospective Studies, Risk Factors, Chest Pain diagnosis, Echocardiography, Stress economics, Emergency Medical Services economics, Exercise Test economics, Health Care Costs
Abstract

This study compared the cost-effectiveness of dobutamine-atropine stress echocardiography (DASE) and electrocardiographic exercise testing (EET) implemented in emergency department accelerated diagnostic protocols for the early stratification of low-risk patients presenting with acute chest pain (ACP). One hundred ninety-nine patients with ACP, nondiagnostic electrocardiographic results, and negative biomarker results were randomized to DASE (n = 110) or EET (n = 89) <6 hours after emergency department presentation. Patients with negative risk assessment results were immediately discharged and followed for 2 months. Ninety patients (82%) in the DASE arm and 78 (88%) in the EET arm were discharged after the diagnosis of nonischemic ACP. The mean lengths of stay in the hospital were 23 +/- 12 and 31 +/- 23 hours in the DASE and EET arms, respectively (p = 0.01). No 2-month follow-up events occurred in DASE patients, and the event rate was significantly higher in EET patients (0% vs 11%, p = 0.004). The DASE strategy showed lower costs compared with the EET strategy at 1-month ($1,026 +/- $250 vs $1,329 +/- $1,288, p = 0.03) and 2-month ($1,029 +/- 253 vs $1,684 +/- $2,149, p = 0.005) follow-up. In conclusion, early DASE in emergency department triage of low-risk patients with ACP is safe and reduces costs of care compared to EET.

Published
2007
Full Text
View/download PDF

40. The impact of plasma high-sensitivity C-reactive protein levels on cardiovascular risk stratification of hypertensive patients: results of the ICEBERG study.

Author

Kozan O, Buyukozturk K, Ilerigelen B, Kabakci G, and Koylan N

Subjects
Adult, Aged, Antihypertensive Agents therapeutic use, Blood Pressure physiology, Cardiovascular Diseases blood, Cardiovascular Diseases prevention & control, Female, Humans, Hypertension blood, Hypertension drug therapy, Male, Middle Aged, Primary Health Care, Risk Factors, C-Reactive Protein metabolism, Cardiovascular Diseases diagnosis, Hypertension diagnosis
Abstract

The Intensive/Initial Cardiovascular Examination Regarding Blood Pressure Levels: Evaluation of Risk Groups (ICEBERG) study focused on the impact of high-sensitivity C-reactive protein (hs-CRP) measurement on cardiovascular risk evaluation. The ICEBERG study comprised 2 subprotocols. Each subprotocol had 2 patient profiles: patients previously diagnosed with essential hypertension and under medical treatment and patients with systolic blood pressure 130 mm Hg or higher, or diastolic blood pressure 85 mm Hg or higher, with no treatment for at least 3 months before inclusion. Measurement of hs-CRP and cardiovascular risk stratification were performed according to European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines. A total of 1817 patients were analyzed. In 1 group, the percentage of patients in "high" plus "very high" added-risk groups increased from 59.2% to 72.7% when hs-CRP data were added to routine serum biochemistries. In another, the increase was from 66.9% to 77.9%, whereas in a third group, it changed from 65.1% to 77.2%. The use of plasma hs-CRP levels might help in stratifying hypertensive patients into specific risk groups and modifying preventive approaches.

Published
2007
Full Text
View/download PDF

41. Evaluation of the metabolic syndrome in hypertensive patients: results from the ICEBERG Study.

Author

Kabakci G, Koylan N, Kozan O, Buyukozturk K, and Ilerigelen B

Subjects
Adult, Aged, Blood Glucose analysis, Cholesterol, HDL blood, Diabetes Mellitus epidemiology, Epidemiologic Studies, Female, Humans, Hypertension complications, Male, Metabolic Syndrome complications, Middle Aged, Obesity complications, Obesity epidemiology, Risk Assessment methods, Statistics, Nonparametric, Triglycerides blood, Turkey epidemiology, Hypertension blood, Hypertension epidemiology, Metabolic Syndrome epidemiology
Abstract

The Intensive/Initial Cardiovascular Examination Regarding Blood Pressure Levels: Evaluation of Risk Groups (ICEBERG) study was aimed at evaluating the components of the metabolic syndrome (MS) for cardiovascular risk stratification in hypertensive patients. The ICEBERG study consisted of 2 subprotocols: ICEBERG-1, conducted at 20 university hospitals, and ICEBERG-2, conducted at 197 primary health care centers. Each subprotocol had 2 patient profiles: patients diagnosed with hypertension and receiving medical treatment (treated group) and patients who had not received antihypertensive treatment (untreated group). MS was defined in the Third Report of the National Cholesterol Education Program Adult Treatment Panel as the presence of at least 3 of the following abnormalities: decreased plasma high-density lipoprotein cholesterol level, increased plasma triglyceride level, hypertension, increased fasting glucose level, and obesity. In a total of 4039 patients, 65.0% had MS, 30.2% had 3 components, 15.0% had 2 components, and 24.8% had 4 components. The most common accompanying component to hypertension was abdominal obesity. Therefore, this study underlined the value of questioning metabolic components in patients with high-normal or high blood pressure to identify individuals with high added risk of cardiovascular disease.

Published
2007
Full Text
View/download PDF

42. Intensive cardiovascular examination regarding blood pressure levels: evaluation of risk groups. ICEBERG study.

Author

Buyukozturk K, Ilerigelen B, Kabakci G, Koylan N, and Kozan O

Subjects
Aged, Albuminuria, Blood Pressure Determination, Cardiovascular Diseases epidemiology, Carotid Arteries diagnostic imaging, Electrocardiography, Female, Humans, Hypertension complications, Hypertension drug therapy, Male, Methods, Middle Aged, Risk Factors, Ultrasonography, Blood Pressure, Cardiovascular Diseases diagnosis, Diagnostic Techniques, Cardiovascular standards, Hypertension epidemiology
Abstract

Objective: Assessment of total cardiovascular risk level is crucial for approaching hypertensive patients. Therefore, the aim of the Intensive/Initial Cardiovascular Examination regarding Blood pressure levels: Evaluation of Risk Groups (ICEBERG) study is to determine cardiovascular risk evaluation and stratification of subjects with high normal and high blood pressure (BP > or = 130/85 mmHg), and to evaluate the impact of laboratory tests on this stratification., Methods: ICEBERG was an epidemiological study conducted at 20 university hospitals and 197 primary healthcare centers. A total of 10,313 patients, who were diagnosed with high BP and under antihypertensive treatment or not antihypertensive under treatment at least for the last 3 months were selected. Besides routine clinical evaluation, microalbuminuria (MAU) and high sensitive C-reactive protein (hs-CRP) tests, echocardiography (Echo) and carotid ultrasonography (USG) were performed in selected arms. The patients were stratified into low, moderate, high and very high added risk groups as described by the European Society of Hypertension/European Society of Cardiology Guidelines Committee (2003)., Results: Upon routine evaluation, the percentage of "high and very high added cardiovascular risk" groups was between 51.2% and 60.7% in different study arms. This percentage increased to 62.9% by subsequent serum biochemistry assessment and to 76.2% by hs-CRP test results. Switching upwards to "high and very high added risk" groups was around 6% when MAU results were used, with a 4.9% upwards switch to "high and very high added risk" groups when Echo was performed; this proportion increased by 6.8%, when carotid USG was taken into account., Conclusion: Cardiovascular risk evaluation by intensive cardiovascular examination including Echo and carotid USG provided more accurate risk stratification. Furthermore, a simple test to demonstrate presence of MAU usable at primary healthcare level will also help to evaluate the patient's risk profile better than routine assessment methods alone.

Published
2006
Full Text
View/download PDF

43. Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed study.

Author

Koylan N, Acarturk E, Canberk A, Caglar N, Caglar S, Erdine S, Guneri S, Ilerigelen B, Kabakci G, Onder R, Sagkan O, and Buyukozturk K

Subjects
Adult, Aged, Blood Pressure, Calcium Channels metabolism, Female, Humans, Irbesartan, Male, Middle Aged, Patient Compliance, Time Factors, Angiotensin-Converting Enzyme Inhibitors pharmacology, Antihypertensive Agents pharmacology, Biphenyl Compounds pharmacology, Calcium Channel Blockers pharmacology, Hypertension drug therapy, Tetrazoles pharmacology
Abstract

Objectives: This multicenter, three-armed, open-labeled study investigated patient compliance of patients receiving irbesartan, angiotensin-converting enzyme (ACE) inhibitors or calcium-channel blockers (CCB) for essential hypertension for a 6-month period. Patients were either newly diagnosed or switched from existing antihypertensive medication due to lack of efficacy or side-effects., Methods: Patients were started monotherapy with irbesartan (n=377), ACE inhibitors (n=298) or CCB (n=308) and were reevaluated on 1st, 3rd, and 6th months of the treatment. The primary endpoint was patient compliance, assessed by proportion of patients who had taken their study medication every day. Efficacy was recorded as mean reductions in blood pressure and the proportion of patients whose blood pressure normalized. Tolerability was assessed by reported adverse events., Results: Significantly more patients receiving irbesartan had complied with study medication after 3 and 6 months of treatment than ACE inhibitors or CCB. Significantly fewer patients receiving irbesartan needed to change their antihypertensive medication. All three study treatments exhibited similar efficacy profiles, but irbesartan had significantly less adverse events., Conclusions: This study demonstrated that patient compliance to irbesartan was significantly superior to other study treatments. Irbesartan is therefore a suitable first-line therapy for essential hypertension in everyday clinical practice.

Published
2005

44. Evaluation of the left ventricular systolic and diastolic functions by echocardiography in patients with acute leukemia.

Author

Tunçkale A, Ilerigelen B, and Aktuğlu G

Subjects
Acute Disease, Adolescent, Adult, Aged, Anemia, Iron-Deficiency diagnostic imaging, Anemia, Iron-Deficiency physiopathology, Diastole, Echocardiography, Evaluation Studies as Topic, Female, Humans, Leukemia diagnostic imaging, Male, Middle Aged, Predictive Value of Tests, Systole, Leukemia physiopathology, Leukemic Infiltration, Ventricular Function, Left physiology
Abstract

Eighteen patients with acute leukemia were studied to evaluate their left ventricular systolic and diastolic function by M mode, two-dimensional and Doppler echocardiographic techniques. The study group was compared with another group of 18 patients of similar age with iron deficiency anemia. The latter group had a comparable heart rate and levels of Hb. There were no differences in systolic function, whereas the diastolic function was lower in patients with acute leukemia (E/A ratio = 1.1 +/- 0.3 vs. 1.42 +/- 0.5, p < 0.05). It is concluded that left ventricular diastolic dysfunction is more common in patients with acute leukemia and may be an indicator of restrictive cardiomyopathy.

Published
1999
Full Text
View/download PDF

45. Simulated myocardial infarction and slow atrial flutter due to cerebral embolism from a free left atrial thrombus.

Author

Onat A, Sarioğlu T, Ilerigelen B, and Domaniç-Uçişik N

Subjects
Adult, Atrial Flutter diagnosis, Electrocardiography, Female, Heart Atria, Humans, Myocardial Infarction diagnosis, Atrial Flutter etiology, Heart Diseases complications, Intracranial Embolism and Thrombosis complications, Myocardial Infarction etiology, Thrombosis complications
Abstract

The case of a 38-year-old female who suffered a cerebral embolism from a free left atrial thrombus is reported. The clinical picture, including serum enzyme elevations, was consistent with a nontransmural myocardial infarction. Atrial flutter exhibiting very slow (162/min) and tall waves was transiently recorded indicating development of an intra-atrial conduction disturbance.

Published
1991
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results